Internationale Publikationen
Hier stellen wir eine Auswahl wissenschaftlicher Veröffentlichungen zur Verfügung, die im Zusammenhang mit der IOZK-Immuntherapie stehen.
Sie können mit Hilfe der Filter eine Auswahl nach Tumorarten und Methoden treffen, oder Suchbegriffe eingeben.
Tumour cell kinetics as predictors of response in canine lymphoma treated with chemotherapy alone or combined with whole body hyperthermia
/in Hyperthermia, International Publications, Malignant Lymphoma /von 1999-11-01 / Int J Hyperthermia 1999 Nov-Dec;15(6):475-86Induction of carcinoembryonic antigen (CEA)-specific cytotoxic T-lymphocyte responses in vitro using autologous dendritic cells loaded with CEA peptide or CEA RNA in patients with metastatic malignancies expressing CEA
/in Colorectal Cancer, Dendritic Cells, International Publications /von 1999-07-02 / Int. J. Cancer 1999 Jul;82(1):121-4Deep hyperthermia with radiofrequencies in patients with liver metastases from colorectal cancer
/in Colorectal Cancer, Hyperthermia, International Publications /von 1999-07-01 / Anticancer Res. 1999 Jul-Aug;19(4C):3403-8A Phase I study of active immunotherapy with carcinoembryonic antigen peptide (CAP-1)-pulsed, autologous human cultured dendritic cells in patients with metastatic malignancies expressing carcinoembryonic antigen
/in Breast Cancer, Colorectal Cancer, Dendritic Cells, International Publications, Ovarian Cancer, Pancreatic Cancer /von 1999-06-01 / Clin. Cancer Res. 1999 Jun;5(6):1331-8Use of Newcastle disease virus vaccine (MTH-68/H) in a patient with high-grade glioblastoma
/in Glioblastoma, International Publications, Newcastle Disease Virus /von 1999-05-05 / JAMA 1999 May;281(17):1588-9Cutting edge: receptor-mediated endocytosis of heat shock proteins by professional antigen-presenting cells
/in Hyperthermia, International Publications /von 1999-04-01 / J. Immunol. 1999 Apr;162(7):3757-60For the clinical application of thermochemotherapy given at mild temperatures
/in Hyperthermia, International Publications /von 1999-03-01 / Int J Hyperthermia 1999 Mar-Apr;15(2):79-107Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells
/in Dendritic Cells, Hypernephroma, International Publications /von 1999-03-01 / J. Urol. 1999 Mar;161(3):777-82Tumor stimulator cell modification by infection with Newcastle Disease Virus: analysis of effects and mechanism in MLTC-CML cultures
/in International Publications, Newcastle Disease Virus /von 1999-02-01 / Int. J. Oncol. 1999 Feb;14(2):205-15[Hyperthermia in combination with chemotherapy in gynecological cancers]
/in Hyperthermia, International Publications /von 1999-01-09 / Ned Tijdschr Geneeskd 1999 Jan;143(2):85-8A pilot study of melphalan, tumor necrosis factor-alpha and 41.8 degrees C whole-body hyperthermia
/in Hyperthermia, International Publications /von 1999-01-01 / Cancer Chemother. Pharmacol. 1999;43(5):409-14Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus
/in International Publications, Newcastle Disease Virus /von 1999-01-01 / Gene Ther. 1999 Jan;6(1):63-73Characterization of mild whole-body hyperthermia protocols using human breast, ovarian, and colon tumors grown in severe combined immunodeficient mice
/in Colorectal Cancer, Hyperthermia, International Publications /von 1999-01-01 / Infect Dis Obstet Gynecol 1999;7(1-2):91-7Mature dendritic cells induce T-helper type-1-dominant immune responses in patients with metastatic renal cell carcinoma
/in Dendritic Cells, Hypernephroma, International Publications /von 1999-01-01 / Urol Int 1999;63(3):151-9Introduction of adhesive and costimulatory immune functions into tumor cells by infection with Newcastle Disease Virus
/in International Publications, Newcastle Disease Virus /von 1998-12-01 / Int. J. Oncol. 1998 Dec;13(6):1105-15A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire
/in International Publications, Malignant Melanoma, Newcastle Disease Virus /von 1998-12-01 / Mol. Med. 1998 Dec;4(12):783-94Dendritic cell immunization breaks cytotoxic T lymphocyte tolerance in hepatitis B virus transgenic mice
/in Chronic Virus Hepatitis, International Publications /von 1998-11-01 / J. Immunol. 1998 Nov;161(9):4520-9[Current methods of radiation therapy in patients with prostatic cancer: subtotal body radiation, local hyperthermia]
/in Hyperthermia, International Publications, Prostate Cancer /von 1998-09-01 / Vestn Rentgenol Radiol 1998 Sep-Oct;(5):30-3Pulsing of dendritic cells with cell lysates from either B16 melanoma or MCA-106 fibrosarcoma yields equally effective vaccines against B16 tumors in mice
/in Dendritic Cells, International Publications, Soft Tissue Sarcoma /von 1998-06-01 / J Surg Oncol 1998 Jun;68(2):79-91Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA
/in Colorectal Cancer, Dendritic Cells, International Publications /von 1998-04-01 / Nat. Biotechnol. 1998 Apr;16(4):364-9